Celiac Drug May Prevent Reaction to Gluten Cross Contamination

As many of you know, I do not have a celiac disease diagnosis. My doctor suspects that I may be celiac. If I were diagnosed, I would participate in the celiac study that is outlined in this article. If you still get a reaction to gluten cross contamination and for other reasons, check it out and see if you qualify. – Carla

CeliAction Research Study on Gluten Cross Contamination

Even when you try your best to stay gluten-free, you never know for sure if something you’ve eaten has been cross-contaminated or mislabeled until after the fact. Most people with celiac disease can relate to accidentally ingesting gluten and then paying the price later on.

Well, there is research currently underway to evaluate if an investigational drug can reduce the symptoms of unintentional exposure to gluten. If proven effective, the drug would offer a new way to manage celiac disease and supplement a gluten-free diet by reducing the risk of gluten’s impact on the body. The best part is that you have to stay on your gluten-free diet in order to participate – no gluten challenge!

The clinical research study is called the CeliAction Study and you may qualify if you:

  • Have been diagnosed with celiac disease by a healthcare professional
  • Are attempting to be on a gluten-free diet
  • Have experienced at least one moderate or severe symptom of celiac disease in the past month

If you participate in the CeliAction Study, you:

  • Will be able to maintain your current diet restrictions
  • Will be provided with study-related care at no cost
  • Do not need medical insurance to take part
  • May be compensated for time and travel
  • Will help advance medical research for celiac disease

To learn more about this research study and see if you qualify, visit [LINK NO LONGER EXISTS.]
or call 1-855-3333-ACT.

Disclaimer: This post is sponsored by the representatives of the CeliAction Study. Its content and the replies to comments left below will be made by representatives of the CeliAction Study and are approved by the Institutional Review Board (IRB). The IRB is a committee that has been formally designated by the US Food and Drug Administration (FDA) to approve, monitor, and review biomedical and behavioral research involving humans. IRBs are responsible for critical oversight functions for research conducted on human subjects that are “scientific,” “ethical,” and “regulatory.”  The CeliAction™ Study is fully IRB-compliant.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Enable Notifications    OK No thanks